Balyasny Asset Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,219
Closed -$132K 3648
2025
Q4
$132K Buy
+60,219
New +$96.9K ﹤0.01% 2936
2024
Q2
Sell
-314,061
Closed -$2.32M 3197
2024
Q1
$2.32M Buy
+314,061
New +$2.64M ﹤0.01% 1499

Other funds holding GUTS

Balyasny Asset Management's GUTS Position: Q1 2026 in Review

Balyasny Asset Management sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 60,219 shares — an estimated $132K sold.

Balyasny Asset Management first reported a position in GUTS in Q1 2024 and held it in 2 quarters. The position peaked at $2.32M in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Balyasny Asset Management reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 60,219 Fractyl Health shares in Q1 2026, an estimated $132K.
  • Balyasny Asset Management first reported a position in Fractyl Health in Q1 2024 and held it in 2 quarters.
  • Balyasny Asset Management's Fractyl Health position peaked at $2.32M in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.